<DOC>
	<DOC>NCT00357292</DOC>
	<brief_summary>To compare the ocular tolerance, the safety and the ocular pharmacokinetics of 3 concentrations (0.5% - 1.0% - 1.5%) and the vehicle of T1225 after one drop instillation</brief_summary>
	<brief_title>Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers</brief_title>
	<detailed_description>The aim of the present study was to compare the ocular tolerance, safety and the ocular pharmacokinetics after a single administration of T1225 eye drops (0.5%, 1.0%, or 1.5%) in healthy volunteers.</detailed_description>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Eye Infections</mesh_term>
	<mesh_term>Eye Infections, Bacterial</mesh_term>
	<criteria>Male or female aged from 18 to 45 years old; Written informed consent; Healthy volunteers (without any ocular symptom); Normal ocular examination in both eyes (corrected visual acuity (VA) &gt;= 6/10 Slit lamp examination without clinical relevant abnormalities Tear breakup time (BUT) â‰¥10 seconds Lachrymal secretion in the Schirmer test &gt;= 10 mm in 5 minutes Lissamine green test total score &lt; 4 +). Ocular trauma, infection or inflammation within the last 3 months; Blepharitis; Conjunctival hyperaemia (score &gt;= 2 +); Watering (score &gt;= 2); Contact lenses; Ocular surgery, including LASIK and PRK, within the last 12 months; Topical ocular treatment within the last month; Systemic antibiotics within the last 7 days; Any medication during the study (except: Paracetamol and contraceptives).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>